These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
339 related articles for article (PubMed ID: 11482875)
1. Flavopiridol induces apoptosis and caspase-3 activation of a newly characterized Burkitt's lymphoma cell line containing mutant p53 genes. Rapoport AP; Simons-Evelyn M; Chen T; Sidell R; Luhowskyj S; Rosell K; Obrig T; Hicks D; Hinkle PM; Nahm M; Insel RA; Abboud CN Blood Cells Mol Dis; 2001; 27(3):610-24. PubMed ID: 11482875 [TBL] [Abstract][Full Text] [Related]
2. The cyclin-dependent kinase inhibitor flavopiridol potentiates gamma-irradiation-induced apoptosis in colon and gastric cancer cells. Jung C; Motwani M; Kortmansky J; Sirotnak FM; She Y; Gonen M; Haimovitz-Friedman A; Schwartz GK Clin Cancer Res; 2003 Dec; 9(16 Pt 1):6052-61. PubMed ID: 14676132 [TBL] [Abstract][Full Text] [Related]
3. Flavopiridol induces cell cycle arrest and p53-independent apoptosis in non-small cell lung cancer cell lines. Shapiro GI; Koestner DA; Matranga CB; Rollins BJ Clin Cancer Res; 1999 Oct; 5(10):2925-38. PubMed ID: 10537362 [TBL] [Abstract][Full Text] [Related]
4. Apoptosis induced in Burkitt's lymphoma cells via Gb3/CD77, a glycolipid antigen. Mangeney M; Lingwood CA; Taga S; Caillou B; Tursz T; Wiels J Cancer Res; 1993 Nov; 53(21):5314-9. PubMed ID: 8221667 [TBL] [Abstract][Full Text] [Related]
5. Flavopiridol, an inhibitor of cyclin-dependent kinases, induces growth inhibition and apoptosis in bladder cancer cells in vitro and in vivo. Wirger A; Perabo FG; Burgemeister S; Haase L; Schmidt DH; Doehn C; Mueller SC; Jocham D Anticancer Res; 2005; 25(6B):4341-7. PubMed ID: 16309238 [TBL] [Abstract][Full Text] [Related]
6. Flavopiridol potentiates the cytotoxic effects of radiation in radioresistant tumor cells in which p53 is mutated or Bcl-2 is overexpressed. Hara T; Omura-Minamisawa M; Kang Y; Cheng C; Inoue T Int J Radiat Oncol Biol Phys; 2008 Aug; 71(5):1485-95. PubMed ID: 18640498 [TBL] [Abstract][Full Text] [Related]
7. Sequential dependent enhancement of caspase activation and apoptosis by flavopiridol on paclitaxel-treated human gastric and breast cancer cells. Motwani M; Delohery TM; Schwartz GK Clin Cancer Res; 1999 Jul; 5(7):1876-83. PubMed ID: 10430095 [TBL] [Abstract][Full Text] [Related]
8. Potential mechanism of resistance to TRAIL-induced apoptosis in Burkitt's lymphoma. Tafuku S; Matsuda T; Kawakami H; Tomita M; Yagita H; Mori N Eur J Haematol; 2006 Jan; 76(1):64-74. PubMed ID: 16343273 [TBL] [Abstract][Full Text] [Related]
9. Insights into apoptosis mechanisms induced by DNA-damaging agents in Burkitt's lymphoma cells. Simões Magluta EP; Vasconcelos FC; Maia RC; Klumb CE Cancer Invest; 2009 Oct; 27(8):830-5. PubMed ID: 19557576 [TBL] [Abstract][Full Text] [Related]
10. Rapid induction of apoptosis by combination of flavopiridol and tumor necrosis factor (TNF)-alpha or TNF-related apoptosis-inducing ligand in human cancer cell lines. Kim DM; Koo SY; Jeon K; Kim MH; Lee J; Hong CY; Jeong S Cancer Res; 2003 Feb; 63(3):621-6. PubMed ID: 12566305 [TBL] [Abstract][Full Text] [Related]
11. Wild-type p53 induces apoptosis in a Burkitt lymphoma (BL) line that carries mutant p53. Ramqvist T; Magnusson KP; Wang Y; Szekely L; Klein G; Wiman KG Oncogene; 1993 Jun; 8(6):1495-500. PubMed ID: 8502475 [TBL] [Abstract][Full Text] [Related]
12. Inhibition of oxidative phosphorylation underlies the antiproliferative and proapoptotic effects of mofarotene (Ro 40-8757) in Burkitt's lymphoma cells. Cariati R; Zancai P; Righetti E; Rizzo S; De Rossi A; Boiocchi M; Dolcetti R Oncogene; 2003 Feb; 22(6):906-18. PubMed ID: 12584570 [TBL] [Abstract][Full Text] [Related]
13. Flavopiridol mediates cell cycle arrest and apoptosis in esophageal cancer cells. Schrump DS; Matthews W; Chen GA; Mixon A; Altorki NK Clin Cancer Res; 1998 Nov; 4(11):2885-90. PubMed ID: 9829756 [TBL] [Abstract][Full Text] [Related]
14. Induction of apoptosis and down regulation of cell cycle proteins in mantle cell lymphoma by flavopiridol treatment. Venkataraman G; Maududi T; Ozpuyan F; Bahar HI; Izban KF; Qin JZ; Alkan S Leuk Res; 2006 Nov; 30(11):1377-84. PubMed ID: 16624404 [TBL] [Abstract][Full Text] [Related]
15. Rhabdoid tumor growth is inhibited by flavopiridol. Smith ME; Cimica V; Chinni S; Challagulla K; Mani S; Kalpana GV Clin Cancer Res; 2008 Jan; 14(2):523-32. PubMed ID: 18223228 [TBL] [Abstract][Full Text] [Related]
16. The cyclin-dependent kinase inhibitor flavopiridol induces apoptosis in multiple myeloma cells through transcriptional repression and down-regulation of Mcl-1. Gojo I; Zhang B; Fenton RG Clin Cancer Res; 2002 Nov; 8(11):3527-38. PubMed ID: 12429644 [TBL] [Abstract][Full Text] [Related]
17. [Therapeutic effect of flavopiridol, a small molecular cyclin-dependent kinase inhibitor, in human ovarian carcinoma]. Song Y; Shen K; Tang PP Zhonghua Fu Chan Ke Za Zhi; 2007 Nov; 42(11):761-4. PubMed ID: 18307904 [TBL] [Abstract][Full Text] [Related]
18. Involvement of caspase activation and mitochondrial stress in trichostatin A-induced apoptosis of Burkitt's lymphoma cell line, Akata. Son YO; Choi KC; Lee JC; Kook SH; Lee HJ; Jeon YM; Kim JG; Kim J; Lee WK; Jang YS J Cell Biochem; 2006 Dec; 99(5):1420-30. PubMed ID: 16817225 [TBL] [Abstract][Full Text] [Related]